Tumor-associated DCs (TADCs) can release several growth factors and other molecules, including TGF-β, granulocyte-macrophage colony-stimulating factor (GM-CSF), CXCL12, and TNFα, which are all proangiogenic factors. The gene discussed is CSF2; the disease is neoplasm.